Neurogene
NGNE
Neurogene (NGNE) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$1.05
- EPS estimate
- −$1.16
- EPS surprise
- +9.47%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 11, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 11, 2025 | −$1.16 | −$1.05 | +9.47% | $0.00 | SEC |
| Q1 2025 | May 9, 2025 | −$1.05 | −$1.08 | −2.86% | $0.00 | SEC |
| Q4 2024 | Mar 24, 2025 | −$1.13 | −$1.00 | +11.42% | $0.00 | SEC |
| Q3 2024 | Nov 18, 2024 | −$1.22 | −$1.19 | +2.59% | $0.00 | SEC |
| Q2 2024 | Aug 9, 2024 | −$1.05 | −$1.09 | −3.85% | $925,000.00 | SEC |
| Q1 2024 | May 10, 2024 | −$1.03 | −$1.00 | +3.29% | $0.00 | SEC |
| Q4 2023 | Mar 18, 2024 | −$1.17 | $2.93 | +349.72% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$0.60 | −$2.47 | −311.67% | $0.00 | SEC |
| Q1 2023 | May 8, 2023 | −$4.40 | −$5.20 | −18.18% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$6.09 | −$4.80 | +21.13% | $0.00 | SEC |
| Q2 2022 | Aug 9, 2022 | −$6.00 | −$5.60 | +6.67% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$5.96 | −$5.60 | +6.04% | $0.00 | SEC |
| Q4 2021 | Mar 1, 2022 | −$5.91 | −$5.60 | +5.31% | $0.00 | SEC |
| Q3 2021 | Nov 4, 2021 | −$5.57 | −$5.60 | −0.60% | $0.00 | SEC |
| Q2 2021 | Aug 5, 2021 | −$5.24 | −$5.40 | −3.05% | $0.00 | SEC |
| Q1 2021 | May 12, 2021 | −$4.56 | −$5.40 | −18.42% | $0.00 | SEC |
| Q4 2020 | Mar 25, 2021 | −$4.89 | −$4.40 | +9.94% | $0.00 | SEC |
| Q3 2020 | Nov 9, 2020 | −$4.40 | −$0.80 | +81.82% | $0.00 | SEC |
| Q2 2020 | Aug 12, 2020 | −$4.20 | −$4.00 | +4.76% | $0.00 | SEC |
| Q1 2020 | May 6, 2020 | −$4.60 | −$3.60 | +21.74% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Neurogene (NGNE) last report earnings?
Neurogene last reported on Aug 11, 2025, covering fiscal Q2 2025.
Did NGNE beat earnings estimates?
Yes. Neurogene reported EPS of −$1.05 for Q2 2025 against a −$1.16 estimate — a 9.47% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.